Melanostatin

In simple words

Melanostatin is a nine-amino-acid peptide for creams that interferes with the skin's production of pigment. It is studied as a gentle ingredient for lightening dark spots that does not damage pigment cells.

What this molecule is

A synthetic nonapeptide (9 aa), a derivative of MIF-1. An α-MSH antagonist for cosmetic skin brightening.

Why it is studied

A melanogenesis inhibitor — a safe alternative to hydroquinone without cytotoxicity toward melanocytes. Reversible lightening of dark spots, melasma, and post-acne marks. Does not kill melanocytes — only ↓pigment synthesis.

How it works

MC1R receptor antagonist on melanocytes → blocks the cAMP-dependent cascade → ↓MITF → ↓tyrosinase → ↓conversion of L-tyrosine to L-DOPA and further to melanin. Reversible effect: melanocytes stay alive, and synthesis recovers after discontinuation.

Doses used in studies

Studies used 1–5% in a serum or cream twice a day for an 8–12-week course. Microneedles improved penetration 2- to 22-fold.

Combined with in studies

• Vitamin C — additional mechanism: ↓tyrosinase + antioxidant
• Niacinamide — ↓melanosome transport
• EGCG
• Melanotan I/II — NOT combined — opposite mechanisms at MC1R

Level of evidence

Level C Animal studies. Effects have been shown in animals. Whether they carry over to humans has not been proven. Mainly in vitro and ex vivo. No clinical RCTs registered.

Important to know

⚠️ Cosmetic ingredient only; no clinical RCTs. Data come mainly from laboratory models.

Studies in PubMed

1. Melanostatin, a new melanin synthesis inhibitor. Production, isolation, chemical properties, structure and biological activity. (J Antibiot (Tokyo), 1991)
2. Up- or Downregulation of Melanin Synthesis Using Amino Acids, Peptides, and Their Analogs. (Biomedicines, 2020)
3. Microneedle enhanced delivery of cosmeceutically relevant peptides in human skin. (PLoS One, 2014)
4. Enhanced skin benefits of EGCG loaded in nonapeptide-1-conjugated mesoporous silica nanoparticles to reverse skin photoaging. (Int J Pharm, 2024)
5. Identification of small peptides and glycinamide that inhibit melanin synthesis using a positional scanning synthetic peptide combinatorial library. (Br J Dermatol, 2019)
6. Improvement in major depression after low subcutaneous doses of MIF-1. (J Affect Disord, 1994)